[HTML][HTML] Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease

I Beltran-Hortelano, V Alcolea, M Font… - Bioorganic & medicinal …, 2022 - Elsevier
Chagas disease (CD) is a centenarian neglected parasitosis caused by the protozoan
Trypanosoma cruzi (T. cruzi). Despite the continuous efforts of many organizations and …

A “Golden Age” for the discovery of new antileishmanial agents: current status of leishmanicidal gold complexes and prospective targets beyond the trypanothione …

LB Rosa, RL Aires, LS Oliveira, JV Fontes… - …, 2021 - Wiley Online Library
Leishmaniasis is one of the most neglected diseases worldwide and is considered a serious
public health issue. The current therapeutic options have several disadvantages that make …

Mode of action of p-quinone derivatives with trypanocidal activity studied by experimental and in silico models

A Ballesteros-Casallas, C Quiroga, C Ortiz… - European Journal of …, 2023 - Elsevier
Quinones are attractive pharmacological scaffolds for developing new agents for the
treatment of different transmissible and non-transmissible human diseases due to their …

New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase

C Espinosa-Bustos, M Ortiz Pérez… - Pharmaceutics, 2022 - mdpi.com
To develop novel chemotherapeutic alternatives for the treatment of Chagas disease, in this
study, a set of new amino naphthoquinone derivatives were synthesised and evaluated in …

New benzimidazolequinones as trypanosomicidal agents

C López-Lira, RA Tapia, A Herrera, M Lapier… - Bioorganic …, 2021 - Elsevier
Herein, the design and synthesis of new 2-phenyl (pyridinyl) benzimidazolequinones and
their 5-phenoxy derivatives as potential anti-Trypanosoma cruzi agents are described. The …

In vitro and in vivo trypanocidal efficacy of synthesized nitrofurantoin analogs

L Munsimbwe, A Seetsi, B Namangala, DD N'Da… - Molecules, 2021 - mdpi.com
African trypanosomes cause diseases in humans and livestock. Human African
trypanosomiasis is caused by Trypanosoma brucei rhodesiense and T. b. gambiense …

Insights about resveratrol analogs against trypanothione reductase of Leishmania braziliensis: Molecular modeling, computational docking and in vitro …

AD da Silva, JA Dos Santos, PA Machado… - Journal of …, 2019 - Taylor & Francis
In this work, we combined molecular modeling, computational docking and in vitro analysis
to explore the antileishmanial effect of some resveratrol analogs (ResAn), focusing on their …

Naphthoquinones and derivatives for chemotherapy: perspectives and limitations of their anti-trypanosomatids activities

L Dantas-Pereira, EF Cunha-Junior… - Current …, 2021 - ingentaconnect.com
Chagas disease, Sleeping sickness and Leishmaniasis, caused by trypanosomatids
Trypanosoma cruzi, Trypanosoma brucei and Leishmania spp., respectively, are considered …

Druggable hot spots in trypanothione reductase: novel insights and opportunities for drug discovery revealed by DRUGpy

O Teixeira, P Lacerda, TQ Froes, MC Nonato… - Journal of Computer …, 2021 - Springer
Assessment of target druggability guided by search and characterization of hot spots is a
pivotal step in early stages of drug-discovery. The raw output of FTMap provides the data to …

Hepatoprotective Activity of Leptadenia hastata (Asclepiadaceae) on Acetaminophen‐Induced Toxicity in Mice: In Vivo Study and Characterization of Bioactive …

BRT Galani, BA Owona, DPD Chuisseu… - BioMed Research …, 2020 - Wiley Online Library
Background and Objectives. Leptadenia hastata is a liana from the family of Asclepiadaceae
used in tropical Africa to treat diabetes mellitus. In this study, we investigated its …